AOP Health - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAOP Health

AOP Health

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2019-02-15		Polycythemia vera
Sugammadex amomed	Sugammadex	2023-01-10	2026	Neuromuscular blockade

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Ropeginterferon alfa-2b

myeloid leukemia chronic-phase

,

polycythemia vera

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia

,

essential thrombocythemia

,

healthy volunteers/patients

,

pharmacokinetics

type 1 diabetes mellitus

,

,

,

,

type 2 diabetes mellitus

,

,

,

,

movement disorders

,

central nervous system diseases

,

,

neurodegenerative diseases

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

drug-induced akathisia

,

nervous system diseases

,

chronic hepatitis

,

parkinsonian disorders

,

drug-induced dyskinesia

,

postoperative pain

,

,

,

postherpetic neuralgia

,

liver cirrhosis

,

,

,

castration-resistant prostatic neoplasms

,

non-small-cell lung carcinoma

,

,

alzheimer disease

,

,

thyroid neoplasms

,

thyroid diseases

,

parkinson disease

,

diabetes mellitus

,

chronic hepatitis c

,

,

acquired immunodeficiency syndrome

,

,

immunologic deficiency syndromes

,

small cell lung carcinoma

,

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

,

rheumatoid arthritis

,

,

neuromuscular blockade

,

prostatic neoplasms

,

,

,

chronic renal insufficiency

,

acute coronary syndrome

,

kidney diseases

,

,

,

,

uterine prolapse

,

intestinal obstruction

,

,

spinal diseases

,

delayed emergence from anesthesia

,

,

,

muscle relaxation

,

,

,

,

urinary retention

,

,

female infertility

,

uterine diseases

,

postoperative complications

,

,

wound infection

,

surgical wound infection

pulmonary hypertension

,

pulmonary arterial hypertension

,

,

familial primary pulmonary hypertension

,

congenital heart defects

,

,

eisenmenger complex

,

acquired immunodeficiency syndrome

,

chronic hepatitis c

,

drug-related side effects and adverse reactions

,

Albinterferon alfa-2b

,

neoplasm metastasis

,

,

,

,

,

acquired immunodeficiency syndrome

,

healthy volunteers/patients

,

,

cystic fibrosis

healthy volunteers/patients

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use